Identification of Spermine As an Inhibitor of Erythropoiesis in Patients with Chronic Renal Failure

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1981 Jun 1

PMID 7240411

Citations 16

Authors

H W Radtke

A B Rege

M B Lamarche

D Bartos

F BARTOS

R A Campbell

J W Fisher

Affiliations

Soon will be listed here.

Abstract

Fetal mouse liver and normal human bone marrow cell cultures were used for studies on the inhibition of erythroid colony formation (CFU-E) by sera from anemic patients with end-stage renal failure and the polyamine spermine. Sera from each of eight predialysis uremic anemic patients with end-stage renal failure produced a significant (P < 0.001) inhibition of erythroid colony formation in the fetal mouse liver cell cultures when compared to sera from normal human volunteers. In vivo or in vitro dialysis of the uremic sera with a 3,500-dalton exclusion limit membrane removed the inhibitor from uremic sera. The uremic serum dialysate provided by the membrane fractionation was significantly inhibitory in the erythroid cell cultures. When this dialysate was applied to gel filtration chromatography (Bio-Gel P-2) the inhibitor was found to be in the same molecular weight range as [(14)C]spermine. The polyamine spermine produced a dose-related inhibition of erythroid colony formation (CFU-E) in fetal mouse liver and normal human bone marrow cultures. Thus, the following evidence is provided that the in vitro inhibitor of erythropoiesis found in chronic renal failure patients' sera is identical with the polyamine spermine: (a) the inhibitor and radiolabeled spermine appeared in identical Bio-Gel P-2 effluent fractions; (b) when spermine was added to normal human sera at concentrations reported in sera of uremic patients, and studied in both the fetal mouse liver cell culture and normal human bone marrow cultures, a dose-related inhibition of erythroid colony (CFU-E) formation was noted; and (c) the inhibitory effects of crude uremic serum, uremic serum dialysate, and fractions of uremic serum dialysate from a Bio-Gel column, on erythroid colony formation were completely abolished by the addition of a specific rabbit antiserum to spermine.

Citing Articles

Indoxyl sulfate impairs erythropoiesis by triggering apoptosis and senescence.

Duangchan T, Rattanasompattikul M, Chitchongyingcharoen N, Mas-Oodi S, Promkan M, Rongkiettechakorn N Exp Biol Med (Maywood). 2022; 247(15):1350-1363.

PMID: 35611811 PMC: 9442459. DOI: 10.1177/15353702221097320.

Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review.

Hamza E, Metzinger L, Metzinger-Le Meuth V Cells. 2020; 9(9).

PMID: 32899941 PMC: 7565991. DOI: 10.3390/cells9092039.

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Vanholder R, Pletinck A, Schepers E, Glorieux G Toxins (Basel). 2018; 10(1).

PMID: 29316724 PMC: 5793120. DOI: 10.3390/toxins10010033.

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients.

Huang J, Hsu C, Yang C, Hung C, Huang W Ther Clin Risk Manag. 2016; 12:1797-1803.

PMID: 27932887 PMC: 5135005. DOI: 10.2147/TCRM.S120012.

Calcium sensing receptor modulates extracellular calcium entry and proliferation via TRPC3/6 channels in cultured human mesangial cells.

Meng K, Xu J, Zhang C, Zhang R, Yang H, Liao C PLoS One. 2014; 9(6):e98777.

PMID: 24905090 PMC: 4048219. DOI: 10.1371/journal.pone.0098777.

References

Lertora J, Dargon P, Rege A, Fisher J . Studies on a radioimmunoassay for human erythopoietin. J Lab Clin Med. 1975; 86(1):140-51. View

Ohno Y, Rege A, Fisher J, Barona J . Inhibitors of erythroid colony-forming cells (CFU-E and BFU-E) in sera of azotemic patients with anemia of renal disease. J Lab Clin Med. 1978; 92(6):916-23. View

RATH C, Mailliard J, SCHREINER G . Bleeding tendency in uremia. N Engl J Med. 1957; 257(17):808-11. DOI: 10.1056/NEJM195710242571704. View

Wallner S, Kurnick J, WARD H, Vautrin R, Alfrey A . The anemia of chronic renal failure and chronic diseases: in vitro studies of erythropoiesis. Blood. 1976; 47(4):561-9. View

Chun P, Rennert O, Saffen E, Taylor W . Effect of polyamines on the electrokinetic properties of red blood cells. Biochem Biophys Res Commun. 1976; 69(4):1095-101. DOI: 10.1016/0006-291x(76)90485-x. View

CALLEN I, LIMARZI L . Blood and bone marrow studies in renal disease. Am J Clin Pathol. 1950; 20(1):3-23, illust. DOI: 10.1093/ajcp/20.1.3. View

Radtke H, Frei U, Erbes P, SCHOEPPE W, Koch K . Improving anemia by hemodialysis: effect of serum erythropoietin. Kidney Int. 1980; 17(3):382-7. DOI: 10.1038/ki.1980.44. View

SWENDSEID M, Panaqua M, Kopple J . Polyamine concentrations in red cells and urine of patients with chronic renal failure. Life Sci. 1980; 26(7):533-9. DOI: 10.1016/0024-3205(80)90316-1. View

Ogawa M, PARMLEY R, Bank H, SPICER S . Human marrow erythropoiesis in culture. I. Characterization of methylcellulose colony assay. Blood. 1976; 48(3):407-17. View

10.

Iscove N, Sieber F, Winterhalter K . Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol. 1974; 83(2):309-20. DOI: 10.1002/jcp.1040830218. View

11.

Shaw A . Haemolysis in chronic renal failure. Br Med J. 1967; 2(5546):213-6. PMC: 1841174. DOI: 10.1136/bmj.2.5546.213. View

12.

Bergstrom J, Furst P . Uremic toxins. Kidney Int Suppl. 1978; (8):S9-12. View

13.

Radtke H, Rege A, LAMARCHE M, Fisher J . Characterization of erythroid inhibiting factors (EIF) in patients with anemia of chronic renal failure. Proc Clin Dial Transplant Forum. 1979; 9:179-83. View

14.

Mason E . Gastrointestinal lesions occurring in uremia. Ann Intern Med. 1952; 37(1):96-105. DOI: 10.7326/0003-4819-37-1-96. View

15.

Radtke H, Claussner A, Erbes P, Scheuermann E, SCHOEPPE W, Koch K . Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood. 1979; 54(4):877-84. View

16.

Kaye M . The anemia associated with renal disease. J Lab Clin Med. 1958; 52(1):83-100. View

17.

Cheney K, BONNIN J . Haemorrhage, platelet dysfunction and other coagulation defects in uraemia. Br J Haematol. 1962; 8:215-22. DOI: 10.1111/j.1365-2141.1962.tb06514.x. View

18.

Moriyama Y, Rege A, Fisher J . Studies on an inhibitor of erythropoiesis. II. Inhibitory effects of serum from uremic rabbits on heme synthesis in rabbit bone marrow cultures (38483). Proc Soc Exp Biol Med. 1975; 148(1):94-7. DOI: 10.3181/00379727-148-38483. View

19.

Wallner S, Kurnick J, Vautrin R, WARD H . The effect of serum from uremic patients on erythropoietin. Am J Hematol. 1977; 3:45-55. DOI: 10.1002/ajh.2830030106. View

20.

Caro J, Brown S, Miller O, Murray T, ERSLEV A . Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med. 1979; 93(3):449-58. View